This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Mitchell, S.C. Articles by Smith, R.L. Search for Related Content PubMed PubMed Citation Articles by Mitchell, S.C. Articles by Smith, R.L. Social Bookmarking                         What's this?

Changes in Debrisoquine Hydroxylation Capacity Following Liver Surgery

Department of Pharmacology and Toxicology, St. Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine, London W2 IPG

R.R. Shah

Department of Pharmacology and Toxicology, St. Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine, London W2 IPG

D.G. Clements

Prince of Wales Hospital, Bridgend, Cardiff, CF31 2RQ, UK

R.L. Smith

Department of Pharmacology and Toxicology, St. Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine, London W2 IPG

Liver transplantation or the surgical construction of portacaval shunts may radically alter an individual's debrisoquine hydroxylation capacity. Good clinical management should encompass a full awareness of such changing needs and problems in patients who undergo hepatic surgery.

Human & Experimental Toxicology, Vol. 13, No. 8, 537-541 (1994)
DOI: 10.1177/096032719401300805


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?